Skip to content

The analysis of endometrial microbiota using the test named EMMA/ALICE to improve reproductive outcomes in infertile patients

The analysis of endometrial microbiota using the test named EMMA/ALICE to improve reproductive outcomes in infertile patients - EMMA/ALICE for RIF or RPL in Japan 2019

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036050
Enrollment
300
Registered
2019-03-01
Start date
2019-02-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic endometritis

Interventions

Endometrial tissue will be obtained by aspiration from these patients on the day of endometrial biopsy in day 15-25 of menstrual cycle. Samples of these patients will ill be used for the non-invasive

Sponsors

Kamiya Ladies Clinic
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1, The patients who has IVF-ET therapy 2, The duration of infertility over 3 years 3,Infertile women with history of recurrent implantation failure, defined as three or more failed ETs, undergoing one or more IVF cycle(s).t 4, Infertile women with history of recurrent pregnancy loss, defined as two ore more 5, Infertile women with history of recurrent chemical pregnancy, defined as two ore more 6,The patients suspected CE by hysteroscope 7,The patients who detected CD138 positive plasma cells in historical tissues 8, The patients who had bacterial vaginosis 9,BMI: 18.5 - 30 kg / m2 (both inclusive) 10,HIV, HBV, HCV, RPR negative

Exclusion criteria

Exclusion criteria: 1, The patients who has endometrial polyp, submucosal myopia, Asherman syndrome, scar of C/S in uterus. 2,Any social, medical, or psychiatric condition 3, The couple or their parents who has chromosomal aberration or carrier of translocation 4, The patients with untreated hydrosalpinx 5, Known allergy to any component of antibiotic therapy 6,,Vaginal or systemic antibiotic therapy within 3 months

Design outcomes

Primary

MeasureTime frame
The clinical pregnancy rate of the patients whose results are abnormal in EMMA/ALICE and after that who have treated with probiotics therapy

Countries

Japan

Contacts

Public ContactNanako Iwami

Kamiya Ladies Clinic Reproductive Center

nanakoiwami@gmail.com011-231-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026